Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial — Jackie Bosch (2017) | RDL Network
Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial
Article 2017 en
Authors
JB
Jackie Bosch
JE
John W. Eikelboom
SC
Stuart J. Connolly
Abstract
1 min read
COMPASS will provide information on the efficacy and safety of rivaroxaban, alone or in combination with aspirin, in the long-term management of patients with stable CAD or PAD, and on the efficacy and safety of pantoprazole in preventing upper GI complications in patients receiving antithrombotic therapy.
Thomas Vanassche, Peter Verhamme, Darryl P. Leong, Deepak L. Bhatt, Olga Shestakovska, Aldo Maggioni, Keith A.A. Fox, Eva Muehlhofer, Stuart J. Connolly, Salim Yusuf, John W. Eikelboom, Jackie Bosch
Mukul Sharma, Robert G. Hart, Stuart J. Connolly, Jackie Bosch, Olga Shestakovska, Kelvin Kuan Huei Ng, Luciana Catanese, Katalin Keltai, Victor Aboyans, Marco Alings, Jong‐Won Ha, George Varigos, Andrew Tonkin, Martin O’Donnell, Deepak L. Bhatt, Keith A.A. Fox, Aldo Maggioni, Scott D. Berkowitz, Nancy Cook Bruns, Salim Yusuf, John W. Eikelboom
Discussion(0)
No comments yet. Be the first to comment.